WO2005070464A3 - A tablet formulation of clopidogrel bisulphate - Google Patents
A tablet formulation of clopidogrel bisulphate Download PDFInfo
- Publication number
- WO2005070464A3 WO2005070464A3 PCT/TR2005/000005 TR2005000005W WO2005070464A3 WO 2005070464 A3 WO2005070464 A3 WO 2005070464A3 TR 2005000005 W TR2005000005 W TR 2005000005W WO 2005070464 A3 WO2005070464 A3 WO 2005070464A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tablet formulation
- clopidogrel bisulphate
- thieno
- new
- bisulphate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2004/00111 | 2004-01-21 | ||
TR200400111 | 2004-01-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005070464A2 WO2005070464A2 (en) | 2005-08-04 |
WO2005070464A3 true WO2005070464A3 (en) | 2005-11-03 |
Family
ID=34806336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/TR2005/000005 WO2005070464A2 (en) | 2004-01-21 | 2005-01-17 | A tablet formulation of clopidogrel bisulphate |
Country Status (2)
Country | Link |
---|---|
TR (1) | TR200505165T1 (en) |
WO (1) | WO2005070464A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070044323A (en) * | 2005-10-24 | 2007-04-27 | 에스케이케미칼주식회사 | Stabilized pharmaceutical oral preparation containing clopidogrel bisulfate |
IS2385B (en) * | 2006-02-10 | 2008-07-15 | Actavis Group Hf. | Clopidogrel bisulfate pharmaceutical compositions |
DK1847258T4 (en) | 2006-04-13 | 2013-04-15 | Acino Pharma Ag | Partial glycerides as lubricant for pharmaceutical compositions containing thieno [3,2-c] pyridine derivatives |
WO2007128476A1 (en) * | 2006-05-04 | 2007-11-15 | Sandoz Ag | Pharmaceutical compositions containing clopidogrel hydrochloride |
CN100400035C (en) * | 2006-10-18 | 2008-07-09 | 深圳信立泰药业股份有限公司 | Clopidogrel sulfate solid preparation, and its preparing method |
HUP0600839A3 (en) * | 2006-11-14 | 2008-09-29 | Egis Gyogyszergyar Nyrt | Solid pharmaceutical composition containing polymorph i of clopidogrel hydrogensulfate and process for the preparation thereof |
EP1970054A3 (en) | 2007-03-14 | 2009-06-03 | Ranbaxy Laboratories Limited | Clopidogrel tablets |
EP2095815B1 (en) | 2008-02-26 | 2011-10-26 | Laboratorios Lesvi, S.L. | Pharmaceutical formulations containing clopidogrel |
EP2107061A1 (en) | 2008-04-02 | 2009-10-07 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process for the preparation of optically enriched clopidogrel |
JP6004524B2 (en) * | 2012-07-11 | 2016-10-12 | 大原薬品工業株式会社 | Method for producing clopidogrel sulfate-containing tablets |
HUP1400294A2 (en) | 2014-06-13 | 2015-12-28 | Skillpharm Kft | Novel application of clopidogrel |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0789875A (en) * | 1993-09-20 | 1995-04-04 | Dai Ichi Seiyaku Co Ltd | Tablet free from disintegration delay |
WO2000066130A1 (en) * | 1999-04-30 | 2000-11-09 | Sanofi-Synthelabo | Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate |
WO2001012194A1 (en) * | 1999-08-11 | 2001-02-22 | Sanofi-Synthelabo | Combinations with antithrombotic activity consisting of clopidogrel hydrogenosulphate and a gpiib/iiia receptor antagonist |
EP1310245A1 (en) * | 2001-11-09 | 2003-05-14 | SHERMAN, Bernard Charles | Clopidogrel bisulfate tablet formulation |
WO2004026879A1 (en) * | 2002-09-19 | 2004-04-01 | Cipla Limited | Clopidogrel |
WO2004074215A1 (en) * | 2003-02-03 | 2004-09-02 | Sunil Sadanand Nadkarni | Process for preparation of clopidogrel, its salts and pharmaceutical compositions |
WO2005048992A1 (en) * | 2003-11-03 | 2005-06-02 | Sandoz Ag | Process for preparing clopidogrel compositions |
-
2005
- 2005-01-17 WO PCT/TR2005/000005 patent/WO2005070464A2/en active Application Filing
- 2005-12-23 TR TR2005/05165T patent/TR200505165T1/en unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0789875A (en) * | 1993-09-20 | 1995-04-04 | Dai Ichi Seiyaku Co Ltd | Tablet free from disintegration delay |
WO2000066130A1 (en) * | 1999-04-30 | 2000-11-09 | Sanofi-Synthelabo | Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate |
WO2001012194A1 (en) * | 1999-08-11 | 2001-02-22 | Sanofi-Synthelabo | Combinations with antithrombotic activity consisting of clopidogrel hydrogenosulphate and a gpiib/iiia receptor antagonist |
EP1310245A1 (en) * | 2001-11-09 | 2003-05-14 | SHERMAN, Bernard Charles | Clopidogrel bisulfate tablet formulation |
WO2004026879A1 (en) * | 2002-09-19 | 2004-04-01 | Cipla Limited | Clopidogrel |
WO2004074215A1 (en) * | 2003-02-03 | 2004-09-02 | Sunil Sadanand Nadkarni | Process for preparation of clopidogrel, its salts and pharmaceutical compositions |
WO2005048992A1 (en) * | 2003-11-03 | 2005-06-02 | Sandoz Ag | Process for preparing clopidogrel compositions |
Non-Patent Citations (1)
Title |
---|
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; MATSUMOTO, TAKAHIRO ET AL: "Pharmaceutical tablets prevented from delayed disintegration", XP002343276, retrieved from STN Database accession no. 123:17941 * |
Also Published As
Publication number | Publication date |
---|---|
TR200505165T1 (en) | 2007-01-22 |
WO2005070464A2 (en) | 2005-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005070464A3 (en) | A tablet formulation of clopidogrel bisulphate | |
AP2006003701A0 (en) | 1H-thieno [2,3-c] pyrazole derivatives useful as kinase inhibitors | |
IL194784A0 (en) | Thieno [3,2-d] pyrimidine derivative useful as pi3k inhibitor | |
WO2006119498A3 (en) | Pharmaceutical compositions with synchronized solubilizer release | |
WO2004093884A3 (en) | High drug load mesalazine sachet | |
WO2005066163A3 (en) | Thiophene derivatives as chk 1 inihibitors | |
WO2007044050A3 (en) | 1h-imidazo[4,5-d]thieno[3,2-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same | |
AU2003218983A1 (en) | Dynamic composition of restricted courses | |
SG127828A1 (en) | Fluorinated alkyl substituted-.thieno[3,4-B]thiophene monomers and polymers therefrom | |
AU2003202259A8 (en) | Lipid compositions, production thereof and of esters | |
IL189667A0 (en) | 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives | |
WO2004072085A3 (en) | Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations | |
IL220432A (en) | Thieno[2,3-b]pyridinedione derivatives and pharmaceutical compositions comprising the same | |
TW200745137A (en) | Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors | |
PL2046797T3 (en) | Furo [3,2-b]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors | |
WO2007025880A3 (en) | Pyrazolone derivatives as 11-beta hsd1 inhibitors | |
AU2003206068A1 (en) | Indolyl-urea derivatives of thienopyridines useful as anti-angiogenic agents | |
WO2007125544A3 (en) | Process for the preparation of polymorphic forms of clopidogrel hydrogen sulfate | |
AU2002221528A1 (en) | Use of hyaluronic acid derivatives for the prevention of inflammatory arthritis | |
WO2009006859A3 (en) | A method of manufacturing 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7- tetrahydrothieno[3,2-c]pyridin-2-yl acetate (prasugrel) | |
WO2007113857A3 (en) | Modified release clopidogrel formulation | |
IL180939A0 (en) | Storage stable hard candy and methods for the production thereof | |
CY1110215T1 (en) | PARTICULAR GLYCERIDES AS LUBRICANTS FOR PHARMACEUTICAL COMPOSITIONS CONTAINING SULIUM PRODUCERS [3,2-c] PYRIDINES | |
CR8678A (en) | POLYFORMIC FORMS OF METHYL ACETATE HYDROBROMIDE (+) - (s) -ALFA - (- 2-CHLOROPHENYL) -6,7-DIHYDROTIENE [3,2-C] PYRIDINE-5 (4H), CLOPIDOGREL HYDROBROMIDE | |
TNSN06311A1 (en) | Clopidogrel salt and polymorphic forms thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005/05165 Country of ref document: TR |
|
122 | Ep: pct application non-entry in european phase |